Status:
ENROLLING_BY_INVITATION
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Medical College of Wisconsin
National Institutes of Health (NIH)
Conditions:
Post-Acute COVID-19
Post-Acute COVID-19 Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
About 10-20% of persons who contract SARS CoV-2 will experience persistent post-acute sequelae of SARSCoV-2 infection (referred here as PASC). While treatments offered at emerging outpatient COVID rec...
Detailed Description
About 10-20% of persons who contract SARS CoV-2 will experience persistent post-acute sequelae of SARSCoV-2 infection (referred here as PASC). Given that persistent symptoms are heterogeneous with mul...
Eligibility Criteria
Inclusion
- 18 years if age or older
- English or Spanish speaking
- Previously tested positive for COVID
- Still having symptoms not explained by any other etiologies
- Cognitive impairment
- Fatigue
Exclusion
- Participation in another clinical trial
- Score greater than 12 on the fatigue scale
- Score greater than 30 on the memory/thinking scale
- Severe cognitive impairment (i.e. Alzheimer's, Dementia)
- Mental or physical inability to participate in the program
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT06156202
Start Date
November 15 2023
End Date
March 30 2026
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19145